Endocrinology - Obesity and Lipids

Obesity is a prevailing and growing public health problem. Overweight and obesity are the major risk factors for cardiovascular disease. Many cardiovascular disease risk factors are elevated in overweight and obese individuals, including dyslipidemia and inflammation, among others. Adiponectin, a hormone secreted by adipose tissue, has both metabolic and anti-inflammatory properties. Multiple studies have described the relationship between adiponectin and obesity in several human populations. On average, obese women give birth to babies with high fat mass. Placental lipid metabolism alters fetal lipid delivery. LDL Cholesterol plays a prominent role in this "diabetic dyslipidemia" and is considered strongly atherogenic, more a cause than a simple marker of increased risk. The variant known as VLDL, very low-density lipoprotein, seems particularly dangerous--though it appears a rise in HDL, high density lipoprotein cholesterol may moderate its destructive action, even without a corresponding drop in LDL numbers.

  • Track 1-1 Lipodystrophy syndromes
  • Track 2-2 Feminizing Hormone Therapy
  • Track 3-3 Maternal Obesity
  • Track 4-4 Placental lipid metabolism
  • Track 5-5 Elevated Cholesterol icd 10
  • Track 6-6 Prader-Willi syndrome
  • Track 7-7 Bardet-Biedl syndrome

Related Conference of Diabetes & Endocrinology